Delivery Order SPE2DB22D2206-SPE2DB26FDQ92
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,468.22 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,808.28 for TREMFYA 100 mg/ml syringes on October 14, 2025, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the federal...
- The Defense Logistics Agency awarded a delivery order valued at $42,826.81 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $12,601 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes, with an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded on September 26, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. TREMFYA is a prescription medication used primarily for dermatological conditions, and this delivery order represents a specific...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.40 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive procurement of a specialized pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,029.90 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical product, with an ultimate completion date of September 29, 2025. This competitively awarded contract, issued on September 26, 2025, utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,720.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml, a pharmaceutical product, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,522.26 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical product on September 19, 2025, with a completion date of September 22, 2025. This firm fixed price contract, with no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat certain immune-mediated inflammatory...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDQ92Delivery Order
The Defense Logistics Agency awarded a $28,277.48 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on October 16, 2025, with an ultimate completion date of October 17, 2025. This contract utilizes a firm fixed-price structure and was competitively awarded without set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. TREMFYA, a pharmaceutical product for dermatological use, represents one of many specialty medications the company delivers through this contract vehicle to support Defense Health Agency and other federal healthcare system customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 10/16/25 |